Norvegia: Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital H
Data licitatiei 08.11.2024
Expirat
7
7
Valoare estimata : 3,000,000
|
Tip anunt:
UE
|
ID: 8818143
|
Data publicarii :
04.10.2024
|
Tara/Judet:
NO |
Descriere scurta:
Norvegia: Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital H
Coduri CPV:
33690000-3 - Diverse medicamente
33696500-0 - Reactivi de laborator
|
Textul licitației
nbsp;The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above mentioned tests to measure the concentration of the medicines in human serum in patients with autoimmune encephalosis diseases (such as arthritis, Crohn's disease, ulcerative colitis, colorus and multiple sclerosis (MS)). The analyses are part of the disease follow-up, where a monitors medicine concentration.Identificatorul procedurii: 0e4f7ff9-838f-4d49-95ce-767c91d995d2Identificator intern: 2024/867Tip de procedură: DeschisăProcedura este accelerată: nuPrincipalele caracteristici ale procedurii: The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above mentioned tests to measure the concentration of the medicines in human serum in patients with autoimmune encephalosis diseases (such as arthritis, Crohn's disease, ulcerative colitis, colorus and multiple sclerosis (MS)). The analyses are a part of following-up the disease, where one monitors the drug concentration. The total estimated volume for analyses is based on analysis results for 2023 and the first half of 2024 at the immunological section:- Infliximab: Approx. 3,000 infliximab concentration measurements.- Adalimumab: Ca. 2000 adalimumab concentration measurements. The number of